Large number of visitors came to Cosmet’agora last week to discover the last innovations in cosmetic formulation. It was a great opportunity to discuss with leader companies developing active ingredients and to feel emerging trends Read more…
Wounds can exhibit impaired healing, as a consequence of pathologic failure to process one of the normal stage of healing. Wound healing impairment could be characteristic of the treatments of chronic wounds due to immobilisation, Read more…
Cell biology is part of the R&D activity in dermocosmetology. At HCS Pharma, we are developing dermocosmetology assay using our automation platform and high content analysis software.
To find anti-cancer drugs, different cellular modifications can be looked at: cell death effect on proliferating cells either in 2D culture or on spheroids (3D culture), anti-mitotic, anti-migration/invasion, anti-angiogenesis effects… Different assays can be performed to follow these different effects. High content screening is a multi-parametric technology allowing searching for poly-effects drugs.
This summer has been very studious for us with the development and validation of new tests in the oncology field.